SynthAsia has forged a strategic partnership with Shanghai General Hospital, focusing on scientific innovation within the realm of healthcare. The collaboration is set to enhance academic research in the field of diabetic retinopathy, with the dual goals of elevating the field’s academic research standards and propelling academic progress. This partnership aims to foster clinical research and facilitate the translation of research findings into practical applications.
In addition to academic pursuits, the alliance will concentrate on holistic healthcare, contributing to the development of research-oriented hospitals. This comprehensive approach will encompass various aspects, including prevention, healthcare, diagnosis, treatment, and rehabilitation, thereby advancing the high-quality development of China’s medical capabilities. The financial specifics of the agreement have not been disclosed.- Flcube.com
